Co. designs, manufactures and sells a range of medical, surgical and diagnostic devices. Co.'s business units are: Oncology/Surgery, which provides a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the NanoKnife System, an alternative to thermal ablation; Vascular Interventions and Therapies, which supports the medical areas of thrombus management, Atherectomy, peripheral products and venous insufficiency; and Vascular Access, which includes a range of peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters and related accessories and supplies. The ANGO stock yearly return is shown above.
The yearly return on the ANGO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2013 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ANGO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|